This inventor holds 2 USPTO granted patents. Top assignee: Health Research, Inc.. Active years: 2009-2010.
Location History:
- Kenmore, NY (US) (2009)
- Buffalo, NY (US) (2010)
Company Filing History:
Years Active: 2009-2010
Title: Innovations by Harry K. Slocum
Introduction
Harry K. Slocum is an accomplished inventor based in Buffalo, NY (US). He has made significant contributions to the field of cancer therapy through his innovative methods. With a total of 2 patents, Slocum's work focuses on optimizing treatment regimens and reducing side effects associated with chemotherapy.
Latest Patents
One of Slocum's latest patents is a method for optimizing cancer therapy by monitoring the maturation of tumor-associated vasculature using selenium. This invention provides a systematic approach for administering chemotherapeutic agents by monitoring tumor vessel maturation (TVM). The method involves administering a selenium compound to an individual and observing the modulation of TVM to identify the optimal timing for chemotherapy. Additionally, this invention helps determine whether a tumor is likely to respond to chemotherapy based on the increase in TVM following selenium administration.
Another notable patent by Slocum is a method of reducing alopecia and bladder toxicity associated with the anti-cancer agent cyclophosphamide. This method involves administering cyclophosphamide along with a selenium compound to individuals in need of treatment. The selenium compounds can be given before, during, or after the administration of cyclophosphamide, thereby mitigating its adverse effects.
Career Highlights
Harry K. Slocum is associated with Health Research, Inc., where he continues to develop innovative solutions in cancer treatment. His work has garnered attention for its potential to improve patient outcomes and enhance the efficacy of cancer therapies.
Collaborations
Some of Slocum's notable coworkers include Youcef M. Rustum and Karoly Toth. Their collaborative efforts contribute to advancing research in the field of oncology.
Conclusion
Harry K. Slocum's contributions to cancer therapy through his innovative patents demonstrate his commitment to improving treatment methodologies. His work not only addresses the efficacy of chemotherapy but also aims to reduce its side effects, showcasing the importance of innovation in healthcare.